EP1351668 - SUSTAINED RELEASE PHARMACEUTICAL DOSAGE FORMS WITH MINIMIZED PH DEPENDENT DISSOLUTION PROFILES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 21.08.2015 Database last updated on 12.10.2024 | Most recent event Tooltip | 21.08.2015 | No opposition filed within time limit | published on 23.09.2015 [2015/39] | Applicant(s) | For all designated states Supernus Pharmaceuticals, Inc. 1550 East Gude Drive Rockville, MD 20850 / US | [2006/33] |
Former [2003/42] | For all designated states Shire Laboratories Inc. 1550 East Gude Drive Rockville, Maryland 20850 / US | Inventor(s) | 01 /
BURNSIDE, Beth 18613 Tanterra Way Brookeville, MD 20833 / US | 02 /
CHANG, Rong-Kun 13607 Pine View Lane Rockville, MD 20850 / US | 03 /
GUO, Xiaodi 22 Hallmark Dr New City, NY 10956 / US | [2003/42] | Representative(s) | Walcher, Armin Louis Pöhlau Lohrentz Patentanwälte Partnerschaft mbB Merianstraße 26 90409 Nürnberg / DE | [N/P] |
Former [2014/42] | Walcher, Armin Louis, Pöhlau, Lohrentz Patentanwälte Postfach 30 55 90014 Nürnberg / DE | ||
Former [2003/42] | Walcher, Armin Louis, Pöhlau, Lohrentz & Segeth Postfach 3055 90014 Nürnberg / DE | Application number, filing date | 01998126.5 | 20.12.2001 | [2003/42] | WO2001US50773 | Priority number, date | US20000741548 | 20.12.2000 Original published format: US 741548 | [2003/42] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO02058676 | Date: | 01.08.2002 | Language: | EN | [2002/31] | Type: | A1 Application with search report | No.: | EP1351668 | Date: | 15.10.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.08.2002 takes the place of the publication of the European patent application. | [2003/42] | Type: | B1 Patent specification | No.: | EP1351668 | Date: | 15.10.2014 | Language: | EN | [2014/42] | Search report(s) | International search report - published on: | US | 01.08.2002 | (Supplementary) European search report - dispatched on: | EP | 03.01.2007 | Classification | IPC: | A61K9/22 | [2003/42] | CPC: |
A61K9/2027 (EP,US);
A61K9/2009 (EP,US);
A61K9/2013 (EP,US);
A61K9/2031 (EP,US);
A61K9/205 (EP,US);
A61K9/2054 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/42] | Title | German: | PHARMAZEUTISCHE RETARDDOSIERUNGSFORMEN MIT MINIMIERTEN PH-ABHÄNGIGEN AUFLÖSUNGSVERLÄUFEN | [2003/42] | English: | SUSTAINED RELEASE PHARMACEUTICAL DOSAGE FORMS WITH MINIMIZED PH DEPENDENT DISSOLUTION PROFILES | [2003/42] | French: | FORMES DE DOSAGE PHARMACEUTIQUE A LIBERATION PROLONGEE POSSEDANT DES PROFILES DE DISSOLUTION A DEPENDANCE AU PH REDUITE AU MINIMUM | [2003/42] | Entry into regional phase | 26.06.2003 | National basic fee paid | 26.06.2003 | Search fee paid | 26.06.2003 | Designation fee(s) paid | 26.06.2003 | Examination fee paid | Examination procedure | 19.07.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 26.06.2003 | Examination requested [2003/42] | 08.02.2007 | Amendment by applicant (claims and/or description) | 18.06.2008 | Despatch of a communication from the examining division (Time limit: M06) | 22.12.2008 | Reply to a communication from the examining division | 07.12.2010 | Despatch of a communication from the examining division (Time limit: M06) | 08.06.2011 | Reply to a communication from the examining division | 16.05.2012 | Despatch of a communication from the examining division (Time limit: M04) | 21.09.2012 | Reply to a communication from the examining division | 09.10.2012 | Despatch of a communication from the examining division (Time limit: M04) | 13.02.2013 | Reply to a communication from the examining division | 09.04.2013 | Despatch of a communication from the examining division (Time limit: M04) | 08.07.2013 | Reply to a communication from the examining division | 19.09.2013 | Communication of intention to grant the patent | 20.01.2014 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 05.06.2014 | Communication of intention to grant the patent | 11.06.2014 | Receipt of the translation of the claim(s) | 04.09.2014 | Fee for grant paid | 04.09.2014 | Fee for publishing/printing paid | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.06.2008 | Opposition(s) | 16.07.2015 | No opposition filed within time limit [2015/39] | Fees paid | Renewal fee | 29.12.2003 | Renewal fee patent year 03 | 23.12.2004 | Renewal fee patent year 04 | 27.12.2005 | Renewal fee patent year 05 | 27.12.2006 | Renewal fee patent year 06 | 24.12.2007 | Renewal fee patent year 07 | 24.12.2008 | Renewal fee patent year 08 | 28.12.2009 | Renewal fee patent year 09 | 27.12.2010 | Renewal fee patent year 10 | 27.12.2011 | Renewal fee patent year 11 | 26.12.2012 | Renewal fee patent year 12 | 27.12.2013 | Renewal fee patent year 13 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Rights in Rem or Legal Means of Execution | ID: | 01 | For: | AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR | Date: | 12.03.2014 | [2014/18] | Documents cited: | Search | [X]EP0320097 (ELAN CORP PLC [IE]) [X] 1-73 * examples 1,4,6 * * claims 1,6-9 *; | [X]EP0373417 (SCHERING CORP [US]) [X] 1-73 * example 7 * *claims*; | [X]US5229135 (PHILIPPON FRANCIS [FR], et al) [X] 1-73 * column 6, line 53 - column 7, line 30 * * claims 1-3 *; | [X]WO9920223 (NOVO NORDISK AS [DK], et al) [X] 8,9,49,50,60,65 * page 17, line 17 - line 25 ** claims 1,8 *; | [X]WO9921551 (UNIV TEMPLE [US]) [X] 1-73 * page 1, line 3 - line 9 * * examples 1,2 * * claims 1-7 *; | [X]WO0041681 (GRUENENTHAL GMBH [DE], et al) [X] 6,7,70-73 * page 9, line 24 - line 27 * * examples 3,4 * * claims 1,7,8 * | International search | [A]US4968508 (OREN PETER L [US], et al); | [A]US5102668 (EICHEL HERMAN J [US], et al); | [A]US5378474 (MORELLA ANGELO M [AU], et al) |